MedPath

A CLINICAL TRIAL ON POLYCYSTIC OVERIAN SYNDROME

Phase 2
Conditions
Health Condition 1: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2021/12/038533
Lead Sponsor
ational Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PCOS patients with age between 16-35 years suffering from any of the two features in the following â??

Patients having mid body obesity (BMI 26-40)

Patient suffering from oligomenorrhea (Duration of flow less than 2 days, interval between

2 cycles exceeding more than 35 days).

At least one ovary showing PCOD (diagnosed by USG)

ESHRE/ASRM- Rotterdam revised criteria for PCOD, 2003

Exclusion Criteria

Pregnant women.

Patients with BMI less than 26.

Patients suffering from any systemic diseases.

Patient having congenital and structural abnormalities of uterus and adnexa.

Patients having physiological infrequent menstruation.

Lactating mother.

Drug induced amenorrhea/oligomenorrhea.

HIV, VDRL, HBsAg positive.

Patients suffering from pelvic pathology including fibroid uterus, cervical polyp etc.

Woman taking OCPs

HB level less than 7 gm%

Other etiologies (CAH, thyroid dysfunction, hyperprolactinemia, Cushing syndrome etc.)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath